Natco Pharma Limited

Natco Pharma plans to acquire over 35% in Adcock Ingram as it seeks to open up new opportunities in South Africa for both portfolio and market expansion. The Hyderabad, India-based company expects to

Eli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec

Breckenridge Pharmaceutical and its Indian partner Natco Pharma have celebrated US Food and Drug Administration approval for their generic everolimus tablets for oral suspension, referencing Novartis’

With the addition of weight loss and obesity indications and more patient-friendly dosing regimens beginning at the start of the current decade, glucagon-like-peptide-1 (GLP-1) receptor agonists have